Pembrolizumab, exemestane, and leuprolide in premenopausal estrogen receptor-positive/HER2-negative advanced breast cancer
Ontology highlight
ABSTRACT: Pembrolizumab, exemestane, and leuprolide in premenopausal estrogen receptor-positive/HER2-negative advanced breast cancer
PROVIDER: PRJNA1086814 | ENA |
REPOSITORIES: ENA
ACCESS DATA